1 |
CD19
💬
| [5] PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Hematopoietic cell lineage, B cell receptor signaling pathway, Epstein-Barr virus infection, Primary immunodeficiency | Blinatumomab
Blinatumomab
💬
|
Blinatumomab
| [3] 11 11, 46, 49 💬
|
2 |
CD19
💬
| [5] PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Hematopoietic cell lineage, B cell receptor signaling pathway, Epstein-Barr virus infection, Primary immunodeficiency | Obexelimab
Obexelimab
💬
|
Obexelimab
| [4] 13 13, 49, 61, 300 💬
|
3 |
CD19
💬
| [5] PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Hematopoietic cell lineage, B cell receptor signaling pathway, Epstein-Barr virus infection, Primary immunodeficiency | Inebilizumab
Inebilizumab
💬
|
Inebilizumab
| [6] 11 11, 13, 46, 49, 51, 300 💬
|
4 |
CD19
💬
| [5] PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Hematopoietic cell lineage, B cell receptor signaling pathway, Epstein-Barr virus infection, Primary immunodeficiency | Obecabtagene autoleucel
Obecabtagene autoleucel
💬
|
Obecabtagene autoleucel
| [1] 49 49 💬
|
5 |
CD19
💬
| [5] PI3K-Akt signaling pathway PI3K-Akt signaling pathway, Hematopoietic cell lineage, B cell receptor signaling pathway, Epstein-Barr virus infection, Primary immunodeficiency | Tafasitamab
Tafasitamab
💬
|
Tafasitamab
| [1] 51 51 💬
|